LDH levels and left atrial ultrastructural chances in patients with mitral paraprosthetic regurgitation.
OBJECTIVE
The aim of this study was to assess the effect of paraprosthetic regurgitation of mitral mechanical valves to myocardial tissue and lactate dehydrogenase (LDH) level.


METHODS
We compared 19 patients (study group) who had mitral mechanical valve with severe mitral paravalvular regurgitation with 20 patients (control group) who had native valve with severe rheumatic mitral regurgitation. None of the patients had clinical hemolytic anemia. On transesophageal echocardiographic examination, semiquantative evaluation and spatial distribution of regurgitant jets were noted in both of the groups. Five LDH isoenzymes were studied in two groups. Myocardial tissue specimens were taken from the left atrial wall during reoperation. Grids randomly taken were studied under the transmission electron microscope.


RESULTS
Total serum LDH levels of the study group (578 +/- 12 IU/L) were higher than the control group (495 +/- 6.2 IU/L) (p < 0.001). We found LDH1/LDH2 more than 1 in all patients; the ratio was not statistically different in the control group. Electron microscopy revealed the same degree of injury in both groups. Haptoglobin levels were decreased and reticulocyte counts were increased in patients with paraprosthetic valve regurgitation.


CONCLUSIONS
Electron microscopic findings support that myocardial injury contributes to increase of total LDH level and high LDH1/LDH2 ratio. But statistically significant elevation in total LDH level in study group and the stable state of LDH1/LDH2 ratio between two groups showed that hemolysis caused by paraprosthetic regurgitation is the most important factor for the increase of total LDH level, so that high LDH level can be used as a reliable parameter for the diagnosis of intravascular hemolysis in paraprosthetic regurgitation.
Mansuroğlu
Denyan
D
Department of Cardiovascular Surgery, Kosuyolu Heart and Research Hospital, Istanbul, Turkey. dmansuroglu@kosuyolu.gov.tr
Omeroğlu
Suat Nail
SN
Izgi
Akin
A
Ercan
Feriha
F
Yaymaci
Bengi
B
Başaran
Yelda
Y
Yakut
Cevat
C
D000328:Adult; D015415:Biomarkers / Q000097:blood; D001705:Bioprosthesis; D001707:Biopsy, Needle; D016022:Case-Control Studies; D005260:Female; D006325:Heart Atria / Q000473:pathology / Q000648:ultrastructure*; D006350:Heart Valve Prosthesis / Q000009:adverse effects*; D006801:Humans; D007150:Immunohistochemistry; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008297:Male; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D011183:Postoperative Complications / Q000175:diagnosis; D011336:Probability; D011379:Prognosis; D011475:Prosthesis Failure; D012214:Rheumatic Heart Disease / Q000150:complications* / Q000175:diagnosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate; D016896:Treatment Outcome
D015415:Biomarkers; D007770:L-Lactate Dehydrogenase